For pancreatic neuroendocrine tumors, FDA panel backs everolimus. @elizmech reports. http://bit.ly/h0E2Hh
1:41 PM - 12 Apr 2011
0 replies
1 retweet
0 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.